deltatrials
Completed PHASE2 NCT00001256

Steroids and Methotrexate to Treat Systemic Vasculitis

An Open Trial of the Efficacy of Glucocorticoids and Methotrexate (MTX) in the Treatment of Systemic Vasculitis

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions Inflammation Vasculitis Wegener's Granulomatosis
Interventions prednisone and methotrexate
Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Mar 31, 1990 Completion: Feb 29, 2004

Listed as NCT00001256, this PHASE2 trial focuses on Inflammation and Vasculitis and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 5 times since 1990, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Mar 1990

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bethesda, United States